PyroDex

• A focused, rapid and comprehensive pyrogenic contaminant detection service.
• Testing technologies that do not rely on animal testing or animal products.

Vision

PyroDex envisions that its detection systems will become a method of choice to rapidly and reliably test the safety of therapeutic products in the biopharmaceutical industry.

To support this vision, PyroDex seeks to:

• Partner with manufacturers and clinicians to provide rapid safety tests with short turnaround times.
• Provide tools and data that support regulatory decisions about therapeutic product safety.

Core beliefs

From the website, PyroDex's core beliefs include:

• More comprehensive contamination testing leads to safer drugs and devices, better and more successful treatments, more lives saved, and better return on investment.
• Many clinical trial failures are due not only to drug inefficacy or device design flaws, but also to contaminants that current safety testing methods may not detect.

• Uses automated Monocyte Activation Testing (MAT) technology.
• Tests therapeutic products that are injectable or implantable.
• Service is dedicated to microbial contamination detection (pyrogen testing).

Why MAT

Traditional pyrogen tests often rely on horseshoe crab blood cells (LAL tests) or live rabbits.

Limitations of these traditional methods (as described on the PyroDex website):

• Delayed results: tests can take 2–3 weeks, delaying time to market.
• Incomplete scope: they typically detect only bacterial endotoxins, and may miss:
• molds
• yeasts
• viruses
• other non-endotoxin contaminants
• Potential inaccuracy of animal testing: rabbit tests can give inconsistent results because sensitivity varies with age, strain, sex and environment.

Advantages of PyroDex's MAT approach

PyroDex uses an FDA‑approved monocyte activation testing technology that:

• Detects pyrogens of all types, including:
• endotoxins
• non‑endotoxin pyrogens from Gram‑positive bacteria
• viruses
• molds
• yeasts
• Uses human‑sourced monocytes to mimic the human fever response in vivo.
• Provides a quantitative readout, supporting consistent comparison across product batches.

These features are intended to give a more comprehensive view of product safety, by detecting any contaminant that can trigger fever, sepsis, multiple organ failure or death, regardless of its specific molecular structure.

Products and applications

PyroDex's services focus on injectable and implantable therapeutic products, including:

• Injectable medical drugs and biologics.
• Implantable medical devices and medical implants.

The goal is to detect microbial pyrogen contamination before products go into clinical trials or commercial use, supporting safer drugs and better treatment outcomes.

PyroDex partners primarily with:

• Medical drug manufacturers.
• Medical device manufacturers.
• Clinicians and clinical researchers who need safety data on therapeutic products.

Turnaround times for test results

As described on the PyroDex website:

• Standard service: PyroDex can provide a full report on test results in five days.
• Expedited service: For customers who need results sooner, PyroDex offers an expedited option with results within 48 hours.

Turnaround times are calculated from the point at which PyroDex receives suitable samples and starts testing.

How customers begin testing with PyroDex

• Customers with testing needs are invited to contact PyroDex to discuss their requirements.
• The website provides options to "Submit an order" and "Send us Samples" to start the process.
• Phone and email contact details are available in the contact information document for direct coordination.

According to the PyroDex website, Dr. Maouyo:

• Has more than 25 years of experience in industrial biotechnology and academic biomedical research.
• Has focused specifically on microbial detection for roughly a decade.
• Has worked extensively on the development of microbial detection kits and evaluated new microbial detection technologies in the United States and Europe.

Academic and professional background

• Holds a Ph.D. in animal physiology from the University of Sherbrooke (Canada).
• Completed postdoctoral fellowships in microbiology and molecular biology at:
• the University of Montreal, and
• the Johns Hopkins School of Medicine.
• Previously held faculty research positions at:
• Johns Hopkins University School of Medicine, and
• the University of Maryland, Baltimore.
• Most recently served as a senior scientist at a multinational biotech firm before founding PyroDex.

Industrial and regulatory expertise

The website highlights that PyroDex has experience working under relevant industry standards and guidelines, including:

• Good Manufacturing Practices (GMP).
• Good Laboratory Practices (GLP).
• International Organization for Standardization (ISO) standards.
• US and European Pharmacopeia testing guidelines.

This experience underpins PyroDex's role as a specialist provider of microbial contamination and pyrogen detection services for therapeutic products.

Address

701 East Pratt Street, Room 5088 Baltimore, MD 21202 United States

Primary contact details

• Email: customer.service@pyrodextesting.com
• Direct phone: (443) 459‑1374
• Toll‑free phone: (877) 381‑2455
• Fax: (443) 492‑6948
• Lab phone: (410) 220‑2064 ext. 101

Stated business hours

From the PyroDex website:

• Monday: 9:00 am – 5:00 pm
• Tuesday: 9:00 am – 5:00 pm
• Wednesday: 9:00 am – 5:00 pm
• Thursday: 9:00 am – 5:00 pm
• Friday: 9:00 am – 5:00 pm
• Saturday: Closed
• Sunday: Closed

Customers can use the phone numbers or email above to discuss testing needs, arrange sample submission, or request more information about PyroDex's services.

Ask anyway — the agent will say plainly that it is not published rather than guess.